These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27038353)

  • 1. The IMI PROTECT project: purpose, organizational structure, and procedures.
    Reynolds RF; Kurz X; de Groot MC; Schlienger RG; Grimaldi-Bensouda L; Tcherny-Lessenot S; Klungel OH
    Pharmacoepidemiol Drug Saf; 2016 Mar; 25 Suppl 1():5-10. PubMed ID: 27038353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-centre, multi-database studies with common protocols: lessons learnt from the IMI PROTECT project.
    Klungel OH; Kurz X; de Groot MC; Schlienger RG; Tcherny-Lessenot S; Grimaldi L; Ibáñez L; Groenwold RH; Reynolds RF
    Pharmacoepidemiol Drug Saf; 2016 Mar; 25 Suppl 1():156-65. PubMed ID: 27038361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bridging differences in outcomes of pharmacoepidemiological studies: design and first results of the PROTECT project.
    Abbing-Karahagopian V; Kurz X; de Vries F; van Staa TP; Alvarez Y; Hesse U; Hasford J; Dijk Lv; de Abajo FJ; Weil JG; Grimaldi-Bensouda L; Egberts AC; Reynolds RF; Klungel OH
    Curr Clin Pharmacol; 2014 May; 9(2):130-8. PubMed ID: 24218995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The innovative medicines initiative: a European response to the innovation challenge.
    Goldman M
    Clin Pharmacol Ther; 2012 Mar; 91(3):418-25. PubMed ID: 22318619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Registries in European post-marketing surveillance: a retrospective analysis of centrally approved products, 2005-2013.
    Bouvy JC; Blake K; Slattery J; De Bruin ML; Arlett P; Kurz X
    Pharmacoepidemiol Drug Saf; 2017 Dec; 26(12):1442-1450. PubMed ID: 28345151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European Medicines Agency review of post-authorisation studies with implications for the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance.
    Blake KV; Prilla S; Accadebled S; Guimier M; Biscaro M; Persson I; Arlett P; Blackburn S; Fitt H
    Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1021-9. PubMed ID: 22039593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Good Signal Detection Practices: Evidence from IMI PROTECT.
    Wisniewski AF; Bate A; Bousquet C; Brueckner A; Candore G; Juhlin K; Macia-Martinez MA; Manlik K; Quarcoo N; Seabroke S; Slattery J; Southworth H; Thakrar B; Tregunno P; Van Holle L; Kayser M; Norén GN
    Drug Saf; 2016 Jun; 39(6):469-90. PubMed ID: 26951233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Benefits of large healthcare databases for drug risk research].
    Garbe E; Pigeot I
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Aug; 58(8):829-837. PubMed ID: 26092163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Translation and introduction of Guide to Methodological Standards in Pharmacoepidemiology].
    Tian F; Liao X; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):2949-57. PubMed ID: 24471310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reorganisation of European pharmacovigilance. Part 2. From spontaneous reports to agency reviews and decisions.
    Prescrire Int; 2015 Feb; 24(157):50-4. PubMed ID: 25802924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obstacles to transparency over pharmacovigilance data within the EMA.
    Prescrire Int; 2015 Nov; 24(165):278-9. PubMed ID: 26688911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lessons learned on the design and the conduct of Post-Authorization Safety Studies: review of 3 years of PRAC oversight.
    Engel P; Almas MF; De Bruin ML; Starzyk K; Blackburn S; Dreyer NA
    Br J Clin Pharmacol; 2017 Apr; 83(4):884-893. PubMed ID: 27780289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MIHARI project: establishing a new framework for pharmacoepidemiological drug safety assessments by the Pharmaceuticals and Medical Devices Agency of Japan.
    Ishiguro C; Takeuchi Y; Uyama Y; Tawaragi T
    Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):854-9. PubMed ID: 27222073
    [No Abstract]   [Full Text] [Related]  

  • 14. The Nordic prescription databases as a resource for pharmacoepidemiological research--a literature review.
    Wettermark B; Zoëga H; Furu K; Korhonen M; Hallas J; Nørgaard M; Almarsdottir A; Andersen M; Andersson Sundell K; Bergman U; Helin-Salmivaara A; Hoffmann M; Kieler H; Martikainen J; Mortensen M; Petzold M; Wallach-Kildemoes H; Wallin C; Sørensen H
    Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):691-9. PubMed ID: 23703712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A MiniReview of the use of hospital-based databases in observational inpatient studies of drugs.
    Larsen MD; Cars T; Hallas J
    Basic Clin Pharmacol Toxicol; 2013 Jan; 112(1):13-8. PubMed ID: 22901097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacoepidemiology and its input to pharmacovigilance.
    Faillie JL; Montastruc F; Montastruc JL; Pariente A
    Therapie; 2016 Apr; 71(2):211-6. PubMed ID: 27080840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of pharmacoepidemiology in evaluating prescription drug safety in pediatrics.
    Luo X; Doherty J; Cappelleri JC; Frush K
    Curr Med Res Opin; 2007 Nov; 23(11):2607-15. PubMed ID: 17854515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The Innovative Medicine Initiative (IMI)].
    Bril A; Canet E
    Med Sci (Paris); 2008 Oct; 24(10):885-90. PubMed ID: 18950588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aims and approaches of Web-RADR: a consortium ensuring reliable ADR reporting via mobile devices and new insights from social media.
    Ghosh R; Lewis D
    Expert Opin Drug Saf; 2015; 14(12):1845-53. PubMed ID: 26436834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The innovative medicines initiative: a public private partnership model to foster drug discovery.
    Vaudano E
    Comput Struct Biotechnol J; 2013; 6():e201303017. PubMed ID: 24688725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.